Committee Calls for Sweeping Reforms to SBIR Program
House Subcommittee Examines the Role of SBIR in Fostering Medical Breakthroughs
Hearing Testimony
Douglas A. Doerfler, President and CEO MaxCyte, Inc.
Michael Borrus, Founding General Partner, X/Seed Capital
Honorable Amy Comstock Rick, J.D., CEO Parkinson’s Action Network
Melvin Billingsley, Ph.D., President and CEO, Life Sciences Greenhouse of Central Pennsylvania
F. Nicholas Franano, M.D., Founder and Chief Scientific Officer, Proteon Therapeutics, Inc.
Statements
Robert J. Beall, Ph.D., President and CEO, Cystic Fibrosis Foundation
James Stefansic, Ph.D., MBA, Chief Technology Officer, Pathfinder Therapeutics, Inc.
